Vericel's future hinges on scaling MACI, as Epicel and Nexobrid have stalled and face capped demand in niche markets. Read ...

CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.

Ryan Edwards was a drummer for an indie band, worked at VISA Europe, and now runs Audoo, a music tech startup. Here's his ...

To meet the federal target of 82% renewable electricity by 2030, the Clean Energy Council continues to estimate that ...

An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...

After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This ...

Within the AI landscape, quantum computing stocks were some of the biggest winners. In particular, growth investors have taken a liking to smaller developers over the usual suspects in big tech. For ...

C-reactive protein (CRP) is a key inflammation marker that can predict heart attack and stroke risk—often better than LDL ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...